You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 25, 2025

Drug Price Trends for GNP SINUS PRESSURE-PAIN CAPLET


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for GNP SINUS PRESSURE-PAIN CAPLET

Average Pharmacy Cost for GNP SINUS PRESSURE-PAIN CAPLET

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
GNP SINUS PRESSURE-PAIN CAPLET 46122-0443-62 0.07905 EACH 2025-04-23
GNP SINUS PRESSURE-PAIN CAPLET 46122-0443-62 0.07966 EACH 2025-03-19
GNP SINUS PRESSURE-PAIN CAPLET 46122-0443-62 0.07856 EACH 2025-02-19
GNP SINUS PRESSURE-PAIN CAPLET 46122-0443-62 0.08069 EACH 2025-01-22
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Market Analysis and Price Projections for GNP SINUS PRESSURE-PAIN CAPLET

Market Overview

The market for sinus pressure and pain relief medications is robust and growing, driven by the high prevalence of sinusitis and other respiratory conditions. Here are some key points to consider:

Prevalence of Sinusitis

Sinusitis is one of the most common reasons for clinical visits in the United States, leading to 73 million restricted-activity days over one year[3]. This high prevalence rate contributes significantly to the demand for effective sinus pressure and pain relief medications.

Market Growth

The global sinusitis treatment market is expected to register a Compound Annual Growth Rate (CAGR) of 6.4% during the forecast period, partly due to the impact of the COVID-19 pandemic, which has been associated with an increased incidence of sinusitis infections[3].

Product Details: GNP SINUS PRESSURE-PAIN CAPLET

Active Ingredients and Uses

While specific details about the active ingredients in GNP SINUS PRESSURE-PAIN CAPLET are not provided, similar products typically contain a combination of a nasal decongestant, a pain reliever, and sometimes an expectorant. For example, products like SUDAFED® Sinus 12 Hour Pressure + Pain Relief contain pseudoephedrine HCl as a nasal decongestant and naproxen sodium as a pain reliever and fever reducer[1].

Target Market

These caplets are designed to temporarily relieve symptoms such as nasal congestion, headache, sinus congestion and pressure, and minor aches and pains. They are suitable for adults and children aged 12 and older.

Price Trends

Current Pricing

The GNP SINUS PRESSURE PAIN CPL 24CT is currently priced at $6.79 for a pack of 24 caplets, indicating a competitive pricing strategy in the market[2].

Historical Price Data

Price trends for similar sinus congestion and pain relief caplets show minor fluctuations over time. For instance, the price per unit for SINUS CONGESTION-PAIN CAPLET has ranged from $0.075 to $0.083 per unit over recent months, suggesting stable pricing with minimal seasonal or market-driven changes[4].

Market Projections

Forecasted Growth

Given the projected CAGR of 6.4% for the sinusitis treatment market, it is likely that the demand for products like GNP SINUS PRESSURE-PAIN CAPLET will increase. This growth will be driven by the increasing prevalence of sinusitis and the ongoing need for effective over-the-counter (OTC) treatments.

Regional Market Share

North America is expected to maintain a significant share of the sinusitis treatment market due to high health awareness and the active presence of major pharmaceutical companies in the region[3].

Competitive Landscape

Key Players

The market for sinus pressure and pain relief medications is highly competitive, with well-known brands like SUDAFED® and Mucinex® dominating the market. Generic and store-brand options, such as GNP SINUS PRESSURE-PAIN CAPLET, also play a crucial role by offering affordable alternatives without compromising on efficacy[1][5].

Product Differentiation

To remain competitive, products like GNP SINUS PRESSURE-PAIN CAPLET must differentiate themselves through factors such as extended-release formulations, non-drowsy ingredients, and comprehensive symptom relief.

Consumer Preferences

Non-Drowsy Formulations

Consumers increasingly prefer non-drowsy formulations to ensure they can manage their symptoms without compromising their daily activities. Products that offer this benefit, like SUDAFED® Sinus 12 Hour Pressure + Pain Relief, are likely to remain popular[1].

Extended-Release Caplets

Extended-release caplets that provide long-lasting relief (e.g., 12 hours) are also in high demand, as they offer convenience and reduced dosing frequency.

Regulatory and Safety Considerations

FDA Regulations

Any changes in FDA regulations or approvals can significantly impact the market. For example, the expansion of indications for treatments like ClearUp sinus Pain relief by the FDA can influence consumer preferences and market dynamics[3].

Safety Warnings

Products must adhere to safety guidelines, including warnings about potential side effects, interactions, and contraindications, especially for pregnant or breastfeeding women and children[1][5].

Key Takeaways

  • Market Growth: The sinusitis treatment market is expected to grow at a CAGR of 6.4%, driven by high prevalence rates and the impact of COVID-19.
  • Price Stability: Prices for sinus pressure and pain relief caplets are generally stable, with minor fluctuations.
  • Competitive Landscape: The market is highly competitive, with both branded and generic options available.
  • Consumer Preferences: Non-drowsy and extended-release formulations are highly preferred by consumers.
  • Regulatory Considerations: Adherence to FDA regulations and safety guidelines is crucial.

FAQs

Q: What are the common active ingredients in sinus pressure and pain relief caplets? A: Common active ingredients include nasal decongestants like pseudoephedrine HCl, pain relievers like naproxen sodium, and sometimes expectorants like guaifenesin[1][5].

Q: How does the COVID-19 pandemic affect the sinusitis treatment market? A: The COVID-19 pandemic has increased the incidence of sinusitis infections, thereby driving the growth of the market[3].

Q: What is the projected market size for the sinusitis treatment market? A: The market is projected to touch USD 3.13 billion by 2032, with a CAGR of 3.4% from 2023 to 2032[4].

Q: Why is North America a significant market for sinusitis treatments? A: North America has a high prevalence rate of sinusitis and a strong presence of major pharmaceutical companies, contributing to its significant market share[3].

Q: What are the key consumer preferences for sinus pressure and pain relief medications? A: Consumers prefer non-drowsy formulations and extended-release caplets that provide long-lasting relief without compromising daily activities[1].

Sources

  1. SUDAFED® 12-Hour Pressure + Pain Relief for Sinus Headaches. Sudafed.
  2. GNP SINUS PRESSURE PAIN CPL 24CT. Advanced Care.
  3. Sinusitis Treatment Market - Share & Size. Mordor Intelligence.
  4. Drug Price Trends for SINUS CONGESTION-PAIN CAPLET. Drug Patent Watch.
  5. Label: SINUS PRESSURE, PAIN AND COUGH- acetaminophen, dextromethorphan hbr, guaifenesin, phenylephrine hcl tablet, film coated. DailyMed.

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.